How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursive Self-Improvement Now Has a Co-Evolving Evaluator: Cambridge-NVIDIA Paper Raises the Stakes
Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...
Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Richard Lowe, Financial Content Strategist at Coastal Debt Resolve. When Google won the ...
The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...
The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...
Artificial intelligence is rewriting the world and simultaneously inventing a whole new language to describe how it’s doing it. Sit in on any product meeting, pitch, or panel these days, and you’ll ...
In the science of artificial intelligence (AI), there is a concept called technological singularity. It is the most dangerous level of AI, of technology and indeed, of science itself, for a number of ...
Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that ...
Abstract: In this article, we study the recursive algorithms for a class of separable nonlinear models (SNLMs) in which the parameters can be partitioned into a linear part and a nonlinear part. Such ...
Abstract: Multi-user orbital angular momentum (MU-OAM) wireless backhaul systems require precise alignment of transmitted and received OAM beams in line-of-sight (LoS) scenarios. Therefore, a crucial ...
In 2015, AI in drug discovery was still a theoretical pursuit – exciting, but unproven. A few early start-ups were applying deep learning to virtual screening and molecular modelling, but the industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results